CD34 and diabetes mellitus: These data confirm that the effectiveness of stem cell therapy in DM multifactorial, and is probably also dependent on the previously described immunoregulatory properties of CD34+ cells, regeneration of a naive immune system from autologous HSCs, and the possibility of regeneration of β-cells from autologous marrow stem cell.